bispecific antibodies in myeloma: approvals and clinical trials - blood cancer onctalk 2023
Published 6 months ago • 24 plays • Length 3:56Download video MP4
Download video MP3
Similar videos
-
4:11
bispecific antibodies in myeloma: approvals and clinical trials
-
3:53
the future of bispecific antibodies - blood cancer onctalk 2023
-
2:06
patient role in bispecific antibody treatment - blood cancer onctalk 2023
-
1:56
types of bispecific antibodies - blood cancer onctalk 2023
-
1:37
pros and cons of bispecific antibodies - blood cancer onctalk 2023
-
2:53
management of bispecific antibodies side effects - blood cancer onctalk 2023
-
6:06
bispecific antibody treatment in non-hodgkin lymphoma: epcoritamab - blood cancers onctalk 2023
-
4:28
bispecific antibody clinical trials - blood cancer video library 2023
-
3:44
bispecific antibodies in lung cancer - onctalk lung 2023
-
2:52
bispecific antibody treatment in non-hodgkin lymphoma: glofitamab - blood cancers onctalk 2023
-
3:36
q&a: financial or location limitations to bispecific antibody treatments? -blood cancer onctalk 2023
-
4:20
bispecific treatments for multiple myeloma - blood cancers video library
-
3:53
identifying smoldering multiple myeloma patients: risk factors - blood cancer onctalk 2023
-
4:32
what is multiple myeloma? - blood cancer onctalk
-
2:44
the future of multiple myeloma treatment - blood cancer onctalk
-
2:39
q&a: bispecific treatment in lymphoma: key doctor discussions - blood cancer onctalk 2023
-
2:28:27
vod 2023 blood cancer onctalk
-
4:10
what is smoldering multiple myeloma? - blood cancer onctalk 2023